Edmund Huang MD
Assistant Professor, Medicine, University of California Los Angeles David Geffen SOM
Join to View Full Profile
Cedarssinai Comprehensive Transplant Center8900 Beverly Boulevard 2ND floorWest Hollywood, CA 90048
Phone+1 310-248-6528
Fax+1 310-423-4678
Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Nephrology, 2004 - 2006- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2001 - 2004
University of Illinois College of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2003 - 2026
MD State Medical License 2007 - 2010
IL State Medical License 1995 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309) Start of enrollment: 2013 Oct 01
- Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection Start of enrollment: 2019 Mar 01
Publications & Presentations
PubMed
- Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure.Agathe Truchot, Marc Raynaud, Ilkka Helanterä, Olivier Aubert, Nassim Kamar
Journal of the American Society of Nephrology. 2025-04-01 - 1 citationsMicrovascular Inflammation of Kidney Allografts and Clinical Outcomes.Marta Sablik, Aurélie Sannier, Marc Raynaud, Valentin Goutaudier, Gillian Divard
The New England Journal of Medicine. 2025-02-20 - 2 citationsBanff 2022 Kidney Commentary: Reflections and Future Directions.Marion Rabant, Benjamin A Adam, Olivier Aubert, Georg A Böhmig, Marian Clahsen Van-Groningen
Transplantation. 2025-02-01
Press Mentions
Regulatory Press Release: Hansa Biopharma Interim Report January–June 2019July 18th, 2019
Plenary Presentation at the 2019 American Transplant Congress Demonstrates Significant Reduction in Time on the Waitlist for Patients Treated with Imlifidase Compared to Matched ControlsJune 7th, 2019
Study Raises Questions About U.S. Kidney Allocation SystemApril 12th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
